People living with complex chronic conditions like epilepsy increasingly face a landscape that makes it difficult to afford the medications prescribed by their provider. Legislation that limits or prohibits access to copay assistance creates yet another access barrier at a time when we need to be focused on ensuring people can afford and get the medications they need to maintain and improve their quality of life.
Copay card prohibition bills would not allow manufacturer copay assistance at all, or allow it only when no generic equivalent exists.
Copay accumulator bills would not allow the financial assistance provided by a manufacturer to count towards an individual’s deductible. This would mean higher and unanticipated copays at the pharmacy counter because people are not reaching their deductible as early as they used to.
We are supporting legislation that would require that copayments paid in any form, including through a copay assistance program, count toward an individual's deductible or out-of-pocket maximum so that more financial burden is not placed on the individual.